New Key Statistics Module, Z-Score and F-Score
OTCPK:WXIBF Key Ratios
Market Cap $ M | 7,717.81 |
Enterprise Value $ M | 6,798.28 |
P/E(ttm) | 17.22 |
PE Ratio without NRI | 12.51 |
Forward PE Ratio | 13.00 |
Price/Book | 1.40 |
Price/Sales | 3.38 |
Price/Free Cash Flow | 131.82 |
Price/Owner Earnings | 426.47 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,382.00 |
EPS (TTM) $ | 0.11 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 46.70 |
y-y EBITDA Growth Rate % | -12.80 |
EV-to-EBIT | 11.21 |
EV-to-EBITDA | 11.21 |
PEG | 0.27 |
Shares Outstanding M | 4,160.53 |
Net Margin (%) | 19.96 |
Operating Margin % | 26.13 |
Pre-tax Margin (%) | 24.50 |
Quick Ratio | 2.54 |
Current Ratio | 2.78 |
ROA % (ttm) | 6.40 |
ROE % (ttm) | 8.96 |
ROIC % (ttm) | 9.45 |
Dividend Yield % | -- |
Altman Z-Score | 3.81 |
WXIBF Number of Guru Trades
WXIBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:WXIBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:WXIBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WuXi Biologics (Cayman) Inc Insider Transactions
No Available Data
News about OTCPK:WXIBF
Total 0- 1